Chlamydia pneumoniae pneumonia: role of new macrolides.
作者信息
Blasi F, Cosentini R, Tarsia P, Camusso L, Campi E, Arosio C, Allegra L
机构信息
Institute of Respiratory Diseases, University of Milan, Italy.
出版信息
J Chemother. 1995 Nov;7 Suppl 4:117-8.
PMID:8904128
Abstract
摘要
相似文献
1
Chlamydia pneumoniae pneumonia: role of new macrolides.肺炎衣原体肺炎：新型大环内酯类药物的作用
J Chemother. 1995 Nov;7 Suppl 4:117-8.
2
[Chlamydia pneumoniae and other Chlamydia species in community-acquired pneumonia].[社区获得性肺炎中的肺炎衣原体及其他衣原体种类]
Rev Clin Esp. 1998 Sep;198 Suppl 1:30-4.
3
Chlamydia pneumoniae and Mycoplasma pneumoniae.肺炎衣原体和肺炎支原体。
Semin Respir Crit Care Med. 2005 Dec;26(6):617-24. doi: 10.1055/s-2005-925525.
4
[Chlamydia (Chlamydophila) pneumoniae pneumonia].[肺炎衣原体肺炎]
Nihon Rinsho. 2003 Feb;61 Suppl 2:490-5.
5
Pneumonia in children.儿童肺炎
N Engl J Med. 2002 Jun 13;346(24):1916; author reply 1916. doi: 10.1056/NEJM200206133462417.
6
Importance of atypical pathogens of community-acquired pneumonia.社区获得性肺炎非典型病原体的重要性。
Clin Infect Dis. 2000 Aug;31 Suppl 2:S35-9. doi: 10.1086/314058.
7
Empirical therapy of community-acquired pneumonia: macrolides are not ideal choices.社区获得性肺炎的经验性治疗：大环内酯类药物并非理想选择。
Semin Respir Infect. 1997 Dec;12(4):329-33.
8
Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy.社区获得性肺炎治疗方案中针对“非典型”病原体的活性是否必要？联合治疗的问题。
Clin Infect Dis. 2008 Dec 1;47 Suppl 3:S232-6. doi: 10.1086/591409.
9
Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections.肺炎支原体和肺炎衣原体在儿童社区获得性下呼吸道感染中的作用。
Clin Infect Dis. 2001 May 1;32(9):1281-9. doi: 10.1086/319981. Epub 2001 Apr 10.
10
[Chlamydia pneumoniae pneumonia].
Ryoikibetsu Shokogun Shirizu. 1999(24 Pt 2):236-40.
Zotero 插件